Your browser doesn't support javascript.
loading
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Becker, Jürgen C; Ugurel, Selma; Leiter, Ulrike; Meier, Friedegund; Gutzmer, Ralf; Haferkamp, Sebastian; Zimmer, Lisa; Livingstone, Elisabeth; Eigentler, Thomas K; Hauschild, Axel; Kiecker, Felix; Hassel, Jessica C; Mohr, Peter; Fluck, Michael; Thomas, Ioannis; Garzarolli, Marlene; Grimmelmann, Imke; Drexler, Konstantin; Spillner, Alexandra N; Eckhardt, Sebastian; Schadendorf, Dirk.
Afiliação
  • Becker JC; Department of Dermatology, University Hospital Essen, Essen, Germany; Translational Skin Cancer Research, Department of Dermatology and West German Cancer Center, University of Medicine Duisburg-Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Ugurel S; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Leiter U; Centre for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany; German Cancer Consortium, Partner Site Tübingen, Tübingen, Germany.
  • Meier F; Department of Dermatology, University Hospital Dresden, Dresden, Germany; German Cancer Consortium, Partner Site Dresden, Dresden, Germany.
  • Gutzmer R; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany.
  • Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
  • Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Livingstone E; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Eigentler TK; Centre for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany; Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Kiecker F; Department of Dermatology and Venereology, Vivantes Klinikum Berlin Neukölln, Berlin, Germany; Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Hassel JC; Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany; German Cancer Consortium, Partner Site Heidelberg, Heidelberg, Germany.
  • Mohr P; Department of Dermatology, Elbe-Kliniken, Buxtehude, Germany.
  • Fluck M; Department of Oncology Hornheide, Fachklinik Hornheide, Münster, Germany.
  • Thomas I; Centre for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Garzarolli M; Department of Dermatology, University Hospital Dresden, Dresden, Germany.
  • Grimmelmann I; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
  • Drexler K; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
  • Spillner AN; Alcedis, Giessen, Germany.
  • Eckhardt S; Alcedis, Giessen, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, Essen, Germany. Electronic address: dirk.schadendorf@uk-essen.de.
Lancet ; 402(10404): 798-808, 2023 09 02.
Article em En | MEDLINE | ID: mdl-37451295
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Célula de Merkel Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Célula de Merkel Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha